Nestle is launching a new frozen-food brand, Vital Pursuit, aimed at the growing market of consumers who are using GLP-1 drugs like Ozempic and Wegovy.
In October, Walmart's U.S. CEO John Furner told Bloomberg that people who pick up GLP-1 drugs from its pharmacies are buying less food, typically with fewer calories.
But Nestle sees an opportunity to cater to those consumers through Vital Pursuit.
Vital Pursuit's packaging won't include mentions of GLP-1 medications, but Nestle said the company will more directly connect the brand to the drugs on social media.
The food company expects that its global growth will slow this year as inflation-weary consumers buy less of its products.
Persons:
Oprah Winfrey, Elon, Morgan Stanley, John Furner, Nestle, Steve Presley, Laffy, Ferrero, Presley
Organizations:
Nestle, Walmart's U.S, Bloomberg, Vital, North, CNBC, Toll, Lean, Swiss
Locations:
U.S, GLP